WiCell also provides cytogenetic and technical services, establishes scientific protocols and supports basic research on the UW-Madison campus.

The institute established its cytogenetic laboratory to meet the growing needs of academic and commercial researchers to monitor genetic stability in stem cell cultures.

WiCell maintains its stem cell banking facilities, testing and quality assurance laboratories and scientific team in UW–Madison’s University Research Park.

The organization works cooperatively with Waisman Biomanufacturing, a provider of cGMP manufacturing services for materials and therapeutics qualified for human clinical trials.

The following technologies employed by WiCell allow scientists to conduct stem cell research with greater assurance of reproducible results, an expectation for publication in peer-reviewed journals.